About
About Bioforce Medical
Bioforce Medical Technologies Inc. is an Arizona startup developing a research-use service to recover living tumor cells from blood for cancer research.

Founder
Carlos Castellanos
Founder & CEO
Carlos earned his M.S. in Biomedical Engineering at Cornell University in the King lab, where he studied charged biomaterial surfaces and flow-based tumor-cell capture. He previously worked as a chemist at the U.S. Food and Drug Administration.
A survivor of stage IV T-cell leukemia, Carlos founded Bioforce because he wants to help move cancer detection earlier, when treatment options may be better. His work focuses on finding rare tumor cells in blood using their electrical properties rather than relying only on biological markers.
Advisors
Guided by leaders in bioengineering and oncology

Michael R. King, PhD
Scientific Advisor
E.D. Butcher Professor of Bioengineering and Associate Vice President for Research at Rice University, and President of the American Institute for Medical and Biological Engineering (AIMBE). Former Chair of Biomedical Engineering at Vanderbilt University and longtime Editor-in-Chief of Cellular and Molecular Bioengineering. His lab studies how cancer cells adhere and spread in the bloodstream.

Steve Abella, MD
Clinical Advisor
Physician-executive and oncology specialist with more than 35 years in clinical research, academic medicine and biopharmaceutical leadership, including at Amgen and Gilead Sciences. Chief Medical Officer focused on oncology drug development, from pre-IND strategy through registration.
Milestones
What's happening now
- NIH SBIR Phase I proposal submitted (pending review).
- Selected as a semi-finalist for the Nucleate Activator 2027 program.
- A prospective customer has sent us its written requirements for patient-derived tumor cells.
- Preparing BSL-2 lab space in Phoenix for processing patient blood.
Want to work with us?
Researchers, partners and investors: we would like to hear from you.
For research use only. Not for use in diagnostic procedures.